Hong Kong-listed innovative drug stocks continued to decline, with Zai Lab (09688.HK) falling more than 6%, Hengrui Medicine (01276.HK) falling more than 4%, and CSPC Pharmaceutical Group (01093.HK) and WuXi AppTec (02359.HK) following suit.

2026-05-18

Hong Kong-listed innovative drug stocks continued to decline, with Zai Lab (09688.HK) falling more than 6%, Hengrui Medicine (01276.HK) falling more than 4%, and CSPC Pharmaceutical Group (01093.HK) and WuXi AppTec (02359.HK) following suit.